Compare MO & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MO | SYK |
|---|---|---|
| Founded | 1822 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.6B | 140.0B |
| IPO Year | 1994 | 1994 |
| Metric | MO | SYK |
|---|---|---|
| Price | $67.91 | $335.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $63.63 | ★ $431.08 |
| AVG Volume (30 Days) | ★ 7.3M | 1.7M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 6.26% | 1.04% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | 4.12 | ★ 8.40 |
| Revenue | $23,279,000,000.00 | ★ $25,116,000,000.00 |
| Revenue This Year | $3.55 | $9.86 |
| Revenue Next Year | $0.42 | $8.39 |
| P/E Ratio | ★ $16.43 | $40.23 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $53.41 | $328.23 |
| 52 Week High | $70.51 | $404.87 |
| Indicator | MO | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 57.98 | 26.59 |
| Support Level | $65.62 | N/A |
| Resistance Level | $68.60 | $375.26 |
| Average True Range (ATR) | 1.22 | 8.49 |
| MACD | -0.36 | -5.66 |
| Stochastic Oscillator | 49.39 | 12.76 |
Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.